← Back to Search

Crisis Response Planning for Suicide Risk for Suicidal Thoughts

N/A
Waitlist Available
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up administered daily for eight consecutive days
Awards & highlights

Study Summary

This trial will compare how well a self-administered vs. clinician-administered protocol helps Veterans experiencing suicidal ideation.

Eligible Conditions
  • Suicidal Thoughts
  • Suicide Attempt

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~administered daily for eight consecutive days
This trial's timeline: 3 weeks for screening, Varies for treatment, and administered daily for eight consecutive days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Suicide Visual Analog Scale scores from the previous daily assessment
Secondary outcome measures
Change in Crisis Response Plan Use from the previous daily assessment
Change in Patient Health Questionnaire - 2 scores from the previous daily assessment
Change in Positive and Negative Affect Schedule - Short Form scores from the previous daily assessment

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Self-administered Crisis Response PlanExperimental Treatment1 Intervention
Participants will complete a self-guided version of the Crisis Response plan online.
Group II: Clinician-administered Crisis Response PlanActive Control1 Intervention
Clinicians will administer the Crisis Response Plan to 75 military veterans.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Crisis Response Planning for Suicide Risk
2021
N/A
~80

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
827 Previous Clinical Trials
502,676 Total Patients Enrolled

Media Library

Crisis Response Planning for Suicide Risk Clinical Trial Eligibility Overview. Trial Name: NCT04903431 — N/A
Suicidal Thoughts Research Study Groups: Clinician-administered Crisis Response Plan, Self-administered Crisis Response Plan
Suicidal Thoughts Clinical Trial 2023: Crisis Response Planning for Suicide Risk Highlights & Side Effects. Trial Name: NCT04903431 — N/A
Crisis Response Planning for Suicide Risk 2023 Treatment Timeline for Medical Study. Trial Name: NCT04903431 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there opportunity for enrolment in this clinical experiment?

"The clinicaltrials.gov data reveals that this trial is presently enrolling patients, having first been published on December 15th 2021 and most recently modified on September 22nd 2022."

Answered by AI

How many people are currently participating in the experiment?

"Affirmative, according to clinicaltrials.gov's information this trial is recruiting patients. The experiment was initially publicized on December 15th 2021 and has since been adjusted as recently as September 22nd 2022. 150 participants are required from a single medical centre for the study to be successful."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Assessing the Effectiveness of Self- and Clinician-administered Crisis Response Planning for Suicide Risk
Lauren Khazem 2021. "Assessing the Effectiveness of Self- and Clinician-administered Crisis Response Planning for Suicide Risk". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04903431.
~22 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top